We curate a digest of the latest news in our field for advocates, policymakers, community coalitions and all who work toward shaping policies and practices to effectively prevent substance use and treat addiction.
The U.S. Food and Drug Administration has published new draft guidelines to encourage the development of treatments for substance use disorders related to stimulants such as cocaine and methamphetamine, The Hill reports.
A new study finds about 20% of adolescents had major depressive disorder in 2021, but less than half of teens who needed mental health treatment had received any.
New York City health officials have reported more than 3,000 overdose deaths in 2022, the highest number since the department started keeping track in 2000.
Most online marijuana dispensaries lack adequate age verification features and most accept nontraceable payment methods, enabling youth to hide their transactions, a new study finds.
Pregnant women with a history of substance use are at greatly increased risk for having a heart attack or stroke during childbirth, compared with women without a history of substance use, a new study finds.
View our curated digest of the latest research news, including a study measuring time in buprenorphine treatment stages via the impact of cocaine or hazardous alcohol use.
A new study finds parents’ alcohol consumption patterns influence how much their teens drink. Researchers found teens who parents drink at least five days a month or who binge drink are significantly more likely to drink themselves compared with teens whose parents don’t drink or binge drink.
People with opioid use disorder who are prescribed a lower dose of buprenorphine are 20% more likely to discontinue treatment than those who are on a higher dose, a new study concludes.
New data shows the number of prescription opioid pills shipped in the United States plummeted in the second half of the 2010s, at the same time the nationwide overdoses crisis worsened, the Associated Press reports.
Kroger, one of the nation’s largest grocery chains, has reached a potential $1.2 billion agreement in principle to settle a majority of opioid-related lawsuits brought by states, local governments and Native American tribes.
Find more of our must-reads in policy news, including DEA data showing that overdoses soared in the second half of the 2010s even as prescription opioid shipments declined.
View our curated digest of the latest research news, including an examination of differential beliefs about contingency management by providers' ethnicity.
New novel synthetic opioids known as nitazenes may be more powerful than fentanyl and may require more doses of naloxone to reverse an overdose, according to a new study.
View our curated digest of the latest research news, including naloxone use in novel potent opioid and fentanyl overdoses in emergency department patients.
This website uses cookies. We use cookies and similar technologies to give you the best experience. By using this website, you accept our Privacy Policy and Terms of Use.